Vertebroplasty for vertebral fracture

BMJ

Volumn 343, Issue 7815, 2011, Pages

  Wilson, David J ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; CORTICOSTEROID; HORMONE; LOCAL ANESTHETIC AGENT;

AGE DISTRIBUTION; ALCOHOL ABUSE; BODY MASS; CHRONIC DISEASE; CLINICAL PRACTICE; DRUG USE; EDITORIAL; FAMILY HISTORY; HORMONE SUBSTITUTION; HUMAN; INCIDENCE; LIFESTYLE MODIFICATION; LOCAL ANESTHESIA; MORBIDITY; OSTEOPOROSIS; PERCUTANEOUS VERTEBROPLASTY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK FACTOR; SMOKING; SPINAL PAIN; SPINE MALFORMATION; VERTEBRA FRACTURE; BACKACHE; COMPRESSION FRACTURE; FEMALE; MALE; METHODOLOGY; NOTE; SPINE FRACTURE;

BACK PAIN; FEMALE; FRACTURES, COMPRESSION; HUMANS; MALE; SPINAL FRACTURES; VERTEBROPLASTY;

EID: 79960310198     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.d3470     Document Type: Editorial

References (12)

1. Staples MP, Kallmes DF, Comstock BA, Jarvik JG, Osborne RH, Heagerty PJ, et al. Effectiveness of vertebroplasty using individual patient data from two randomised placebo controlled trials: meta-analysis. BMJ 2011;343:d3952.
2. Hippisley-Cox J, Coupland C. Predicting risk of osteoporotic fracture in men and women in England and Wales: prospective derivation and validation of QFractureScores. BMJ 2009;339:b4229.
3. Galibert P, Deramond H, Rosat P, Le Gars D. Preliminary note on the treatment of vertebral angioma by percutaneous acrylic vertebroplasty [in French with English abstract]. Neurochirurgie 1987;33:166-8.
4. Wardlaw D, Cummings SR, Van Meirhaeghe J, Bastian L, Tillman JB, Ranstam J, et al. Efficacy and safety of balloon kyphoplasty compared with non-surgical care for vertebral compression fracture (FREE): a randomised controlled trial. Lancet 2009;373:1016-24.
5. Klazen CA, Lohle PN, de Vries J, Jansen FH, Tielbeek AV, Blonk MC, et al. Vertebroplasty versus conservative treatment in acute osteoporotic vertebral compression fractures (Vertos II): an open-label randomised trial. Lancet 2010;376:1085-92.
6. National Institute for Health and Clinical Excellence. Percutaneous vertebroplasty. 2003. http://guidance.nice.org.uk/IPG12.
7. Buchbinder R, Osborne RH, Ebeling PR, Wark JD, Mitchell P, Wriedt C, et al. A randomized trial of vertebroplasty for painful osteoporotic vertebral fractures. N Engl J Med 2009;361:557-68.
8. Kallmes DF, Comstock BA, Heagerty PJ, Turner JA, Wilson DJ, Diamond TH, et al. A randomized trial of vertebroplasty for osteoporotic spinal fractures. N Engl J Med 2009;361:569-79.
9. Kallmes DF, Jarvik JG, Osborne RH, Comstock BA, Staples MP, Heagerty PJ, et al. Clinical utility of vertebroplasty: elevating the evidence. Radiology 2010;255:675-80.
10. Brinjikji W, Comstock BA, Gray L, Kallmes DF. Local Anesthesia with Bupivacaine and Lidocaine for Vertebral Fracture trial (LABEL): a report of outcomes and comparison with the Investigational Vertebroplasty Efficacy and Safety Trial (INVEST). AJNR Am J Neuroradiol 2010;31:1631-4.
11. Miller FG, Kallmes DF, Buchbinder R. Vertebroplasty and the placebo response. Radiology 2011;259:621-5.
12. Wilson D, Owen S, Corkill R. Facet joint injections as a means of reducing the need for vertebroplasty in insufficiency fractures of the spine. Eur Radiol 2011; online 13 April.